Analyses of cancer risk conferred by pathogenic variants in BRCA1 exon 11 show a reduction in breast cancer risk, but a relative increase in ovarian cancer risk compared to the other regions of the protein (21). This evidence concerns the gene BRCA1 and ovarian cancer.